Armodafinil

(R)-Modafinil

Nuvigil, Waklert, Artvigil, R-Modawake, Neoresotyl

Psychoactive Class

Chemical Class

Diphenylmethylsulfinylacetamide (modafinil analogue)

Armodafinil is a eugeroic substance of the benzhydryl class, consisting of the enantiopure (R)-enantiomer of the racemic mixture modafinil.¹ Approved by the FDA in 2007,¹² it is prescribed to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder.¹ Compared to racemic modafinil, armodafinil is considered more potent and longer-acting.²³⁴ Its effects are primarily functional and wakefulness-promoting rather than overtly recreational.

Dosage & Duration

Dosage

Threshold~20 mg

Light40-100 mg

Moderate100-200 mg

Strong200-300 mg

Heavy300+ mg

Early morning dosing is advised to minimize sleep disruption; afternoon or late-morning administration may result in insomnia and subsequent fatigue. Concurrent food intake delays peak plasma concentration by 2–4 hours, potentially affecting onset and sustained effect. Paradoxical drowsiness has been reported in some individuals.

Duration

Onset20-60 minutes

Come Up1-2.5 hours

Peak4-7 hours

Offset2-5 hours

After Effects2-12 hours

Total8-15 hours

Half-life

~15 hours

Subjective Effects

The armodafinil experience is overwhelmingly functional rather than recreational, centering on a smooth and sustained suppression of fatigue and sleepiness with little else accompanying it. Users who take it while drowsy or mentally tired typically describe simply no longer feeling tired, without a pronounced sense of stimulation or euphoria. Its long duration is a defining feature: doses taken in the afternoon can prevent proper sleep that night and leave the user more fatigued the following day, so early-morning dosing is generally considered advisable. Rarely, hallucinations have been reported as an adverse reaction, particularly in overdose.

Physical

Body load is generally light, with most users not feeling notably stimulated. The most common physical complaints are headache, dry mouth, nausea, dizziness, and difficulty sleeping, with appetite suppression, tremor, and thirst also reported. Overdose can produce restlessness, chest pain, and significantly increased or decreased heart rate along with elevated blood pressure.

Stimulation

Physical stimulation is characteristically subtle; the experience is often described as an absence of tiredness rather than the presence of energy.

Appetite suppression

Uncomfortable

Dry mouth Nausea Dizziness Tremors

Cognitive

The headspace is clear and unremarkable, characterized by wakefulness and sustained mental arousal rather than any distinct alteration of thought or mood. Anxiety, irritability, or low mood can occur as adverse reactions, and euphoria alongside markedly increased activity and talkativeness has been reported in a minority of users.

Emotional

Emotional effects are typically minimal at therapeutic doses, appearing mainly as adverse reactions in susceptible users.

Anxiety

Enhancements

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

The precise mechanism of action of armodafinil is not fully understood.⁵ Its best-characterized activity is binding to the dopamine transporter (DAT) and inhibiting dopamine reuptake,⁵⁶ functioning as an atypical dopamine reuptake inhibitor. This activity is associated with increased extracellular dopamine levels.⁵⁴⁶ Evidence also suggests it may block the norepinephrine transporter (NET),⁴ and the resulting elevations in dopamine and norepinephrine are thought to contribute to its wake-promoting properties. Additional hypothesized contributions include indirect promotion of orexinergic and histaminergic activity⁴ alongside reduction of GABAergic tone.⁴

Pharmacokinetics

Armodafinil is readily absorbed after oral administration,⁵ reaching peak plasma concentrations in approximately 2 hours in the fasted state.⁵ Food has minimal effect on overall bioavailability but may delay peak levels by 2 to 4 hours.⁵ The absolute oral bioavailability has not been determined due to the aqueous insolubility of armodafinil precluding intravenous administration.⁵ The terminal elimination half-life is approximately 15 hours.⁵ The primary metabolic pathway is hydrolytic deamidation, followed by sulfone formation catalyzed by CYP3A4/5.⁵ Additional routes include aromatic ring hydroxylation with subsequent glucuronide conjugation.⁵ Two metabolites reach appreciable plasma concentrations: R-modafinil acid and modafinil sulfone.⁵ Armodafinil moderately induces CYP3A4 and moderately inhibits CYP2C19.⁵

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AlcoholDXMDissociativesHormonal birth controlMAOIsMDMAMXENBOMe compoundsStimulantsTramadol

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

AbemaciclibAbrocitinibAcalabrutinibAcenocoumarolAcetaminophen

TripSit

Tolerance

Full Tolerance

Repeated armodafinil use over time can make many effects less pronounced, leading users to need larger doses for similar results.

Baseline Reset

1-2 weeks

Half Tolerance

3-7 days

Cross Tolerance

Benzhydryl nootropics (modafinil, adrafinil)

Harm Potential

Addiction & Dependence

Psychological

Low

Armodafinil is considered mildly addictive with low abuse potential.⁷ Animal self-administration studies suggest some reinforcing properties,⁷ and it produces psychoactive and euphoric effects comparable to methylphenidate,⁷ though psychological dependence appears uncommon among users.

Toxicity

Dermatological

Serious skin reactions including Stevens-Johnson syndrome can develop in rare cases;⁷ these are hypersensitivity reactions requiring immediate medical attention if any rash develops.

Psychosis Risk

Hallucinations and mania are listed as possible side effects,⁷ particularly at overdose levels.⁷ These effects appear uncommon at typical therapeutic or recreational doses.

History & Culture

Armodafinil is the isolated R-enantiomer of the racemic wakefulness-promoting agent modafinil.⁸ It was developed by Cephalon Inc., a pharmaceutical company that later became a wholly owned subsidiary of Teva Pharmaceutical Industries…

Trip Reports

Legality

By Country

United StatesSchedule IV

Controlled under the Controlled Substances Act as a Schedule IV substance, indicating accepted medical use with low potential for abuse relative to Schedule III drugs.¹⁵¹⁶ Purchasing, selling, or possessing armodafinil without a valid prescription or DEA license is illegal.¹⁶

CanadaSchedule F (Prescription Drug)

Listed as a Schedule F prescription drug under the Food and Drug Regulations. May be lawfully prescribed for both human and veterinary use.

RomaniaRegulated (as modafinil enantiomer)

Not directly scheduled as of 2021, but considered related to modafinil which is classified as a doping agent and will appear on laboratory tests.¹⁴ Simple possession is not a criminal offense but carries administrative penalties including fines and confiscation. Importing or exporting without a valid medical prescription constitutes a criminal offense punishable by two to seven years imprisonment.¹⁴

AustraliaSchedule 4

Classified as a prescription-only medicine or prescription animal remedy under the Poisons Standard.¹² Defined as a substance whose use or supply should be by or on the order of persons permitted by State or Territory legislation to prescribe, available only from a pharmacist on prescription.¹²

GermanyPrescription-only (Anlage 1 AMVV)

Listed in Anlage 1 of the Arzneimittelverschreibungsverordnung (AMVV), the German Prescription Ordinance. Legal possession and dispensing requires a valid prescription from an authorized prescriber.¹³

United KingdomUnscheduled (ambiguous)

Not a licensed medicine and not controlled under the Misuse of Drugs Act 1971. Legal status under the Psychoactive Substances Act 2016 remains uncertain, as racemic modafinil is a licensed prescription-only medicine in the UK. Personal possession without prescription may not constitute a criminal offense, and legal import for personal use may be permissible under Section 13 of the Medicines Act 1968.

References

Source Pages

Citations

Suggest an edit